Abstract
The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 801-805 |
| Number of pages | 5 |
| Journal | Cell Stem Cell |
| Volume | 22 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Jun 1 2018 |
Fingerprint
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology
Cite this
CIRM Alpha Stem Cell Clinics : Collaboratively Addressing Regenerative Medicine Challenges. / Jamieson, Catriona H.M.; Millan, Maria T.; Creasey, Abla A.; Lomax, Geoff; Donohoe, Mary E.; Walters, Mark C.; Abedi, Mehrdad; Bota, Daniela A.; Zaia, John A.; Adams, John S.
In: Cell Stem Cell, Vol. 22, No. 6, 01.06.2018, p. 801-805.Research output: Contribution to journal › Comment/debate
}
TY - JOUR
T1 - CIRM Alpha Stem Cell Clinics
T2 - Collaboratively Addressing Regenerative Medicine Challenges
AU - Jamieson, Catriona H.M.
AU - Millan, Maria T.
AU - Creasey, Abla A.
AU - Lomax, Geoff
AU - Donohoe, Mary E.
AU - Walters, Mark C.
AU - Abedi, Mehrdad
AU - Bota, Daniela A.
AU - Zaia, John A.
AU - Adams, John S.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.
AB - The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.
UR - http://www.scopus.com/inward/record.url?scp=85047211312&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047211312&partnerID=8YFLogxK
U2 - 10.1016/j.stem.2018.05.007
DO - 10.1016/j.stem.2018.05.007
M3 - Comment/debate
C2 - 29859170
AN - SCOPUS:85047211312
VL - 22
SP - 801
EP - 805
JO - Cell Stem Cell
JF - Cell Stem Cell
SN - 1934-5909
IS - 6
ER -